Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +23.17%
#3 Status Status +14.60%
#4 BankrCoin BankrCoin +12.62%
#5 ICON ICON +11.36%
#6 Siren Siren +8.94%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +6.96%
#8 WAX WAX +6.54%
#9 would would +6.30%
#10 Pons Pons +5.44%
Coin of the day
Palladium Network Palladium Network
設定
言語
日本
通貨
USD
テーマ
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
株式のランク #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
株価
$29.82
最終同期: 2023-04-11
時価総額
$223.68M
変化（1日）
1.21%
変化（1年）
0.00%
国
CA
取引 Neovasc Inc. (NVCN)

カテゴリー

Healthcare
Neovasc Inc.（NVCN）の収益
Sep 2026 時点の収益 TTM: 0
Neovasc Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Neovasc Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US